Wellington Management Group LLP reduced its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 20.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 203,513 shares of the semiconductor company's stock after selling 53,386 shares during the period. Wellington Management Group LLP owned about 0.63% of Axcelis Technologies worth $21,338,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the company. Signaturefd LLC grew its position in shares of Axcelis Technologies by 348.9% in the 2nd quarter. Signaturefd LLC now owns 211 shares of the semiconductor company's stock valued at $30,000 after acquiring an additional 164 shares during the period. Blue Trust Inc. raised its position in shares of Axcelis Technologies by 223.8% in the second quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company's stock valued at $39,000 after purchasing an additional 188 shares during the period. Ashton Thomas Private Wealth LLC bought a new stake in shares of Axcelis Technologies during the 2nd quarter worth about $39,000. Isthmus Partners LLC grew its stake in Axcelis Technologies by 87.3% in the 2nd quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company's stock valued at $47,000 after buying an additional 15,507 shares during the last quarter. Finally, Meeder Asset Management Inc. bought a new position in Axcelis Technologies in the 2nd quarter valued at about $69,000. 89.98% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts recently weighed in on ACLS shares. Needham & Company LLC reissued a "hold" rating on shares of Axcelis Technologies in a report on Friday, November 8th. Benchmark cut shares of Axcelis Technologies from a "buy" rating to a "hold" rating in a research report on Friday, November 8th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Axcelis Technologies has an average rating of "Moderate Buy" and an average price target of $167.33.
View Our Latest Report on Axcelis Technologies
Axcelis Technologies Price Performance
NASDAQ ACLS traded down $0.37 on Friday, hitting $75.29. 490,249 shares of the company's stock were exchanged, compared to its average volume of 630,323. Axcelis Technologies, Inc. has a 52 week low of $69.35 and a 52 week high of $158.61. The stock has a 50-day moving average of $84.00 and a 200-day moving average of $107.34. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04. The stock has a market cap of $2.45 billion, a price-to-earnings ratio of 11.14, a P/E/G ratio of 2.36 and a beta of 1.53.
Axcelis Technologies Profile
(
Free Report)
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
See Also
Before you consider Axcelis Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.
While Axcelis Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.